Trial intelligence / Profile preview

Milrinone vs Triple H for Posttraumatic Cerebral Vasospasm

NCT05131867Phase 2Completed

Sponsor
Zagazig University
Start
Nov 2021
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of milrinone in cerebral vasospasm, sponsored by Zagazig University. Started Nov 2021; status: completed.

02

Drugs

milrinone
03

Conditions

cerebral vasospasm

Beyond the preview

Go deeper on NCT05131867.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05131867.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call